Biosynthetic Pathways of the Endocannabinoid Anandamide
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Anandamide (=N‐arachidonoylethanolamine) is the first discovered endocannabinoid, and belongs to the class of bioactive, long‐chain N‐acylethanolamines (NAEs). In animal tissues, anandamide is principally formed together with other NAEs from glycerophospholipid by two successive enzymatic reactions:1)N‐acylation of phosphatidylethanolamine to generate N‐acylphosphatidylethanolamine (NAPE) by Ca 2+‐dependent N‐acyltransferase;2) release of NAE from NAPE by a phosphodiesterase of the phospholipase D type (NAPE‐PLD). Although these anandamide‐synthesizing enzymes were poorly understood until recently, our cDNA cloning of NAPE‐PLD in 2004 enabled molecular‐biological approaches to the enzymes. NAPE‐PLD is a member of the metallo‐β‐lactamase family, which specifically hydrolyzes NAPE among glycerophospholipids, and appears to be constitutively active. Mutagenesis studies suggested that the enzyme functions through a mechanism similar to those of other members of the family. NAPE‐PLD is widely expressed in animal tissues, including various regions in rat brain. Its expression level in the brain is very low at birth, and remarkably increases with development. Analysis of NAPE‐PLD‐deficient mice and other recent studies revealed the presence of NAPE‐PLD‐independent pathways for the anandamide formation. Furthermore, calcium‐independent N‐acyltransferase was discovered and characterized. In this article, we will review recent progress in the studies on these enzymes responsible for the biosynthesis of anandamide and other NAEs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882
Jin, X.-H., Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606369200 · Cited by 155
Self-citation
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Cannabinoid Receptors: Where They are and What They do
Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529
The Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
Supply and demand for endocannabinoids
Alger, B. E., & Kim, J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.03.003 · Cited by 268
Juszczak, G. R., & Swiergiel, A. H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.014 · Cited by 211
“…as an endocannabinoid activating CB1 (EC50=322 nM) and CB2 (EC50=957 nM) cannabinoid receptors (Felder et al., 1995; Priller et al., 1995), and it displays affinity to vanilloid (EC50=6 µM) receptors that are involved in the control of pain (Okamoto et al., 2007; Ross, 2003; Smart et al., 2000).”
BackgroundReduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses
Kim, J., & Alger, B. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2517 · Cited by 149
“N -acylphosphatidylethanolamine–hydrolyzing phospholipase D (NAPE-PLD), a widely studied synthetic enzyme for anandamid”
Nyilas, R., Dudok, B., Urbán, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5102-07.2008 · Cited by 119
“…of synaptic neurotransmission, has been documented for anandamide (Lovinger, 2007), as well as for other NAEs, which exhibit, for example, antiepileptic, antinociceptive (N-palmitoylethanolamine), or anorexic (N-oleoylethanolamine and N-stearoylethanolamine) effects (Okamoto et al., 2007).”
BackgroundInfluentialUyama, T., Morishita, J., Jin, X.-H., Okamoto, Y., Tsuboi, K., & Ueda, N. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800453-jlr200 · Cited by 84
Self-citation
Metadata
- Authors
- Okamoto, Y., Wang, J., Morishita, J., & Ueda, N.
- Venue
- Chemistry & Biodiversity
- Publisher
- Wiley
- Published
- 2007-08
- Volume
- 4
- Issue
- 8
- Pages
- 1842-1857
- ISSN
- 1612-1872 (ISSN-L)
- 1612-1880
- OpenAlex
- W2110625766
- Cited by
- 137
- References
- 4
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.